News
Help Register Login Login Hi, %{firstName}% Hi, %{firstName}% Games Car rental The U.S. Food and Drug Administration (FDA) has green-lit a blood test that can help doctors diagnose Alzheimer’s disease ...
Older adults who spend more time sedentary may be at a higher risk for developing Alzheimer's disease, no matter how much ...
A research team has unveiled the cause and molecular mechanism of chronic brain inflammation that results in repetitive ...
2h
Best Life on MSNFDA Approves First-Ever Alzheimer's Blood Test—Here's Who Will BenefitHowever, that could all change thanks to a new blood test called Lumipulse. On May 16, the U.S. Food & Drug Administration ...
Eisai has put direct-to-consumer (DTC) advertising at the heart of its ongoing efforts to expand demand for Leqembi. | Eisai ...
The FDA cleared marketing for the first in vitro diagnostic device that tests blood to aid in diagnosing Alzheimer disease.
Explore more
Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.
Cognitive reserve is the mind’s resistance to damage the brain.
“Valley of Forgetting,” “The Lost Orchid,” “The Director,” and “Happiness Forever.” ...
9h
Daily Express US on MSNFull list of dementia symptoms as half of Americans undiagnosedAlmost 7 million Americans are affected by Alzheimer's disease and similar dementias, with half of those individuals ...
Frontotemporal dementia (FTD) is a type of dementia that often strikes during middle age, making it difficult to diagnose. Unlike Alzheimer’s disease, which mainly affects memory, FTD impacts ...
WTOP talked to a Georgetown University doctor about an advancement in Alzheimer’s disease testing that he says will help patients get treatment faster.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results